An amended Form 144 notice was filed on November 6, 2026, disclosing that Roxanne Oulman, a director of Klaviyo, Inc., proposes to sell 13,989 Series A shares with an aggregate market value of $284,825.08 through Fidelity Brokerage Services LLC on the NYSE.
Director and 10% owner Andrew Africk filed a Form 4 with the SEC on November 6, 2026, reporting an automatic grant of 11,100 shares of CVD Equipment Corp common stock issued on November 5, 2026, the date of the company's 2026 Annual Meeting of …
Director William K. Pou Jr. filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of 239 shares of SouthState Bank Corp common stock on November 5, 2026, in lieu of cash director fees.
Director Christopher D. Myers filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of 248 shares of Five Star Bancorp common stock on November 4, 2026, at a price of $0 per share under the company's 2021 Equity Incentive …
Barclays PLC filed an amended Schedule 13G with the SEC on November 6, 2026, disclosing a 7.16% beneficial ownership position in Office Properties Income Trust as of September 30, 2026.
On a same-center basis, excluding London, revenue declined about 7.5%, reflecting a 9.6% decline in caseVolumethat was partly offset by a 2.3% increase in average selling price. Average selling price was approximately $12,900. Net loss was $7.173 million, or $0.10 per diluted share, compared …
Net loss was $9.293 million, or $0.73 per diluted share, against a net loss of $5.515 million, or $0.42 per share, in the third quarter of 2025. For the nine months, net loss was $32.577 million, or $2.56 per share, compared with $44.416 million, …
Adjusted net income from continuing operations was $3.9 million, or $0.29 per diluted share, and Adjusted EBITDA was $5.1 million. International viscosupplement revenue increased 19% and total Regenerative Solutions revenue increased 12%. Integrity revenue grew more than 30% year over year.
Net income was $60.6 million, against $54.8 million, andDiluted Earnings per Sharewere $0.74, compared with $0.66. Adjusted earnings per share were $0.77, compared with $0.69 a year earlier.
Adjusted diluted loss was $0.17 per share, against an adjusted diluted loss of $0.03.GAAPdiluted loss per share was $0.03, against a loss of $0.54 a year earlier. The company said the difference between GAAP and adjusted results reflects approximately $12 million of adjustments, primarily …